AIDS-Associated Progressive Multifocal Leukoencephalopathy: Current Management Strategies

ISSN： 1172-7047

Source： CNS Drugs, Vol.19, Iss.8, 2005-01, pp. : 671-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment options for AIDS patients with progressive multifocal leukoencephalopathy

By Hernández Beatriz Dronda Fernando Moreno Santiago

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 3, 2009-02 ,pp. : 403-416

Informa Healthcare

Access to resources Recommend Favorite

No new confirmed cases of progressive multifocal leukoencephalopathy (PML) associated with Tysabri [natalizumab]

Reactions Weekly, Vol. 1, Iss. 1075, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A possible fifth case of Tysabri [natalizumab]-associated progressive multifocal leukoencephalopathy (PML) has been reported to the US FDA.

Reactions Weekly, Vol. 1, Iss. 1057, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

There have been no new cases of progressive multifocal leukoencephalopathy (PML) associated with Tysabri [natalizumab]

Reactions Weekly, Vol. 1, Iss. 1065, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Immunosuppressants: Fatal progressive multifocal leukoencephalopathy?: case report

Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite